Diaoyutai Pharmaceutical Group Jilin Tianqiang Pharmaceutical Co., Ltd. was established in October 2013. Its legal representative is Yan Zhonghui. The company is located at No. 309 Renmin Street, Liuhe County, Jilin Province. The company covers an area of ​​42,000 square meters, has a construction area of ​​18,000 square meters, and has a registered capital of 30 million yuan. There are currently 309 employees and 158 technical personnel of various types, accounting for 51.1%.

Since 2002, the company has carried out GMP transformation, and has successively completed and passed the GMP certification of 8 production lines in 6 modern production workshops. Starting from May 2014, the company was redesigned by Jilin Provincial Medical Design Institute, invested funds to upgrade the original production plant, facilities and equipment, and carried out the transformation of the new version of GMP. In July 2015, the company successfully passed the national new version of GMP certification. The company's production scale is constantly expanding, and the technological content is gradually increasing. In August 2015, the company was successfully listed on the national small and medium-sized enterprise equity transfer system and entered the fast lane of the capital market.

The company currently has 92 major varieties and 104 national drug-accredited font numbers. The leading varieties include Musk Anti-shu Pills, Shujin Capsules, Deer Fetus Paste, Ginseng Royal Jelly, Fish Maw Bushen Pills, etc. After more than ten years of operation, the company has established a good brand image in the pharmaceutical industry. Many core products such as Naoxinshu, Shengmaiyin, Shujin capsules and Yumai Bushen Pills have also been tested by the market and have been deeply influenced by patients and users. Unanimous praise.

The company has always attached great importance to investment in product research and development and the improvement of its own comprehensive R&D strength. In addition to building a research institute with a team of 31 people, the company has successively developed new drugs and generic drugs with Jilin University, Changchun University of Traditional Chinese Medicine, and Beijing Oakland Medical Technology Center. New varieties and new processes and technologies, and the development of 4 new Chinese patent medicines, 30 generic drugs, and 8 generic drugs in Western medicines. At present, the company has obtained 5 invention patents and has accepted 2 patents. It is a joint R&D system based on new drug research and development cooperation. It effectively combines the resources and advantages of both parties, so that the company has sustainable R&D capabilities and rich and effective R&D resources .

In order to ensure that the medicinal materials do not lose their true efficacy and provide high-quality raw materials for drug production, the company built a Chinese medicinal material demonstration base in 2006. Currently, the company has a 102 hectares of Chinese medicinal material planting base, and has completed the standardized cultivation of Chinese medicinal materials Schisandra chinensis and Astragalus. A sika deer breeding base and a forest frog breeding base were also built. The company will further expand the cultivation of Chinese medicinal materials and the breeding of sika deer and forest frogs, and has driven the enthusiasm of surrounding farmers to grow Chinese medicinal materials, truly playing the leading role of agricultural industrialization.

The company now has a strong marketing team and has a marketing network in 30 provinces, cities and autonomous regions across the country. The company has successively established strategic partnerships with Hunan Laobaixing Pharmacy, Zhejiang Weicheng Pharmaceutical Co., Ltd., Northeast Pharmaceutical Group, Harbin Pharmaceutical Group Harbin Pharmaceutical Liu Health Co., Ltd. and other large pharmaceutical companies and interlocking stores across the country, and the company's sales channels are constantly expanding. .

The company has always insisted on selecting natural and authentic Chinese medicinal materials, providing good storage conditions based on the different characteristics of the medicinal materials, high content of the active ingredients of the medicinal materials, and the efficacy of the produced medicines is accurate. During the production process, strictly control the quality, establish a complete quality management system, and have good quality of the medicines produced. Tianqiang Pharmaceuticals has become a good medicine that the people can trust, and Tianqiang Pharmaceuticals will also make greater contributions to the revitalization of the national pharmaceutical industry and benefiting human health.